Sniffing out the aroma(tase) of drug-induced thrombocytopenia
Open Access
- 11 June 2020
- journal article
- editorial
- Published by American Society of Hematology in Blood
- Vol. 135 (24) , 2116-2117
Abstract
In this issue of Blood, Tochigi et al made it their mission to understand the molecular mechanisms by which immunomodulatory drugs (IMiDs) induce thrombocytopenKeywords
This publication has 10 references indexed in Scilit:
- Aromatase is a novel neosubstrate of cereblon responsible for immunomodulatory drug–induced thrombocytopeniaBlood, 2020
- New Insights Into the Differentiation of Megakaryocytes From Hematopoietic ProgenitorsArteriosclerosis, Thrombosis, and Vascular Biology, 2019
- Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical ExperienceDrugs, 2017
- ThrombocytopeniaPrimary Care: Clinics in Office Practice, 2016
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- The incredible journey: From megakaryocyte development to platelet formationJournal of Cell Biology, 2013
- Mechanism of action of lenalidomide in hematological malignanciesJournal of Hematology & Oncology, 2009
- Proplatelet formation of megakaryocytes is triggered by autocrine-synthesized estradiolGenes & Development, 2003
- Faculty Opinions recommendation of Widespread failure of hematolymphoid differentiation caused by a recessive niche-filling allele of the Ikaros transcription factor.2003
- Widespread Failure of Hematolymphoid Differentiation Caused by a Recessive Niche-Filling Allele of the Ikaros Transcription FactorImmunity, 2003